Literature DB >> 11079547

High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid.

K B Chua1, S K Lam, C T Tan, P S Hooi, K J Goh, N K Chew, K S Tan, A Kamarulzaman, K T Wong.   

Abstract

During the outbreak of Nipah virus encephalitis in Malaysia, stored cerebrospinal fluid (CSF) samples from 84 patients (27 fatal and 57 nonfatal cases) were cultured for the virus. The virus was isolated from 17 fatal cases and 1 nonfatal case. There were significant associations between CSF virus isolation and mortality as well as clinical features associated with poor prognosis. In addition, there was a positive linear correlation of CSF virus isolation with age. There was no significant association between CSF virus isolation and the character of the CSF, presence of Nipah-specific antibody in the serum or CSF, duration of illness before collection of samples, or sex or ethnicity of the patients. This study suggests that high viral replication in the central nervous system may be an important factor for high mortality.

Entities:  

Mesh:

Year:  2000        PMID: 11079547

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

3.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

Review 5.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 6.  Emerging viral infections of the nervous system.

Authors:  Richard T Johnson
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 7.  Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Authors:  Ponraj Prabakaran; Zhongyu Zhu; Xiaodong Xiao; Arya Biragyn; Antony S Dimitrov; Christopher C Broder; Dimiter S Dimitrov
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

8.  Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.

Authors:  Alexander N Freiberg; Melissa N Worthy; Benhur Lee; Michael R Holbrook
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

9.  Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.

Authors:  Cyrille Mathieu; Vanessa Guillaume; Valentina A Volchkova; Christine Pohl; Frederique Jacquot; Ren Yih Looi; Kum Thong Wong; Catherine Legras-Lachuer; Viktor E Volchkov; Joel Lachuer; Branka Horvat
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

10.  Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail.

Authors:  Lena Thiel; Sandra Diederich; Stephanie Erbar; Dennis Pfaff; Hellmut G Augustin; Andrea Maisner
Journal:  Virol J       Date:  2008-12-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.